Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	35.19B
Revenue (ttm)	6.29B +12.8%
Net Income	1.04B +35.1%
EPS	2.86 +32.4%
Shares Out	359.44M
PE Ratio	34.94
Forward PE	27.61
Dividend	1.10 (1.09%)
Ex-Dividend Date	Jun 26, 2025

Volume	3,852,204
Average Volume	5,505,294
Open	101.69
Previous Close	101.33
Day's Range	98.73 - 102.20
52-Week Range	59.90 - 125.50
Beta	0.18
RSI	48.89
Earnings Date	Mar 31, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.